Luminex logo

LMNX - Luminex News Story

$36.73 -0.0  -0.1%

Last Trade - 7:45pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.22bn
Enterprise Value £1.14bn
Revenue £298.5m
Position in Universe 2366th / 6849

BRIEF-Luminex Says Received FDA Emergency Use Authorization For COVID-19 Antibody Test

Mon 20th July, 2020 10:12am
July 20 (Reuters) - Luminex Corp  LMNX.O :
    * LUMINEX RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR
COVID-19
ANTIBODY TEST
    * LUMINEX CORP - ANNOUNCED THAT FDA HAS ISSUED AN EMERGENCY
USE
AUTHORIZATION (EUA) FOR COMPANY'S XMAP SARS-COV-2 MULTI-ANTIGEN
IGG ASSAY

Source text for Eikon:  ID:nPn9VdYlHa 
Further company coverage:  LMNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.